AWMDMG
ORMP icon

Austin W. Marxe & David M. Greenhouse’s Oramed Pharmaceuticals ORMP Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$6.37M Hold
790,000
– – 0.87% 38
2014
Q2 		$7.6M Hold
790,000
– – 0.96% 39
2014
Q1 		$9.16M Hold
790,000
– – 1.01% 31
2013
Q4 		$12.2M Buy
+790,000
New +$6.09M 1.31% 23

Other funds holding ORMP

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's ORMP Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Oramed Pharmaceuticals (ORMP) position steady in Q3 2014 at 790,000 shares worth $6.37M. The position accounts for 0.87% of the portfolio, ranked #38.

Austin W. Marxe & David M. Greenhouse first reported a position in ORMP in Q4 2013 and has held it in 4 quarters since. The position peaked at $12.2M in Q4 2013. 19 funds tracked by Wall St. Rank hold ORMP as of Q3 2014.

  • Austin W. Marxe & David M. Greenhouse held 790,000 shares of Oramed Pharmaceuticals worth $6.37M as of Q3 2014.
  • Austin W. Marxe & David M. Greenhouse left its Oramed Pharmaceuticals share count unchanged in Q3 2014.
  • Oramed Pharmaceuticals made up 0.87% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #38 holding.
  • Austin W. Marxe & David M. Greenhouse first reported a position in Oramed Pharmaceuticals in Q4 2013 and has held it in 4 quarters since.
  • Austin W. Marxe & David M. Greenhouse's Oramed Pharmaceuticals position peaked at $12.2M in Q4 2013.
  • 19 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.